NCT06986174
- Conditions
- B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.
NCT06986174
NCT06049290
NCT06237803
NCT06645678
NCT06920251
NCT06485076
NCT05312255
NCT07248176
NCT07136857
NCT00898235